Welcome to the HBOT News Network
Hyperbaric Oxygen Therapy (HBOT) is increasingly appearing in the news and new research as a treatment for a variety of conditions involving inflammation. Use the search or select an article below to keep up to date on the most recent HBOT News.
Recent Hyperbaric Oxygen Therapy (HBOT) News
Listen to Dr Ted Fogarty talk to Dena Marie on Lift Your Spirits (WKKNW, Bellevue, WA) about the benefits of glutathione and hyperbaric oxygen therapy to treat COVID-19.
The NBA star shows Architectural Digest the dedicated self-care space in his Cleveland, Ohio home that includes a hyperbaric chamber. Read the full story on Architectural Digest:...
Listen to Dr. Paul Harch discuss the double standard in medicine, randomized controlled trials versus evidence based medicine as it relates to the use of ventilators, hydroxyclhoriquine, and hyperbaric oxygen therapy for the treatment...
Effectiveness of Hyperbaric Oxygen Therapy for Traumatic Brain Injury: Interview of Paul G. Harch, MD
Nancy Faass interviews Dr. Paul Harch on the Effectiveness of Hyperbaric Oxygen Therapy for Traumatic Brain Injury. In the treatment of traumatic brain injury, the research suggests that hyperbaric oxygen is the most effective therapy...
Christie DeBernardis visits the Kentucky Equine Sports Medicine and Rehabilitation Center to see a Jack Russell Terrier receive a hyperbaric oxygen therapy treatment and learns much more about how HBOT and other therapies are used by...
Hyberbaric Oxygen Treatments have been used for years to treat issues such as anemia, bubbles of air in your blood vessels, and carbon monoxide, just to name a few (according to the Mayo Clinic).But now, it's being used in the fight...
Thomas E Serena, MD of the SerenaGroup, Inc. with the Wound Treatment Center at Opelousas General Hospital in Louisiana have begun a new clinical trial to study COVID-19 patients treated with Hyperbaric Oxygen Therapy under...
Using Hyperbaric Oxygen Therapy for Coronavirus Lung Infection: The time for more HBOT treatment and studies is now
Dr. Paul Harch shares his thoughts on off-label treatment of COVID-19 with HBOT as well as the Institutional Review Board (IRB) approved protocol used for the study he is conducting with the Louisiana State University.For months, the...
HBOT for coronavirus pneumonia and respiratory failure is now being applied to patients around the world clinically and in experimental trials. Dr. Harch explains how it works by answering the question "What is HBOT?" and showing that...
Recent Hyperbaric Oxygen Therapy (HBOT) Research
April 2, 2020, Dr. David Lee posted a new clinical trial on the NIH Clinical Trials website to study the use of Hyperbaric Oxygen Therapy (HBOT) to treat COVID-10. The study is listed as "Not Recruiting Yet," but has an estimated completion date...
Hyperbaric oxygen therapy (HBOT) treatment will be provided to patients as an adjunct to standard therapy for a cohort of 40 COVID19-positive patients with respiratory distress at NYU Winthrop Hospital. All patients prior to the clinical application of HBOT will be evaluated by the primary care team and hyperbaric physician. After the intervention portion of this study, a chart review will be performed to compare the outcomes of intervention patients versus patients who received standard of care.
Clinical Trial – Pseudoephedrine Prophylaxis for Prevention of Middle Ear Barotrauma in Hyperbaric Oxygen Therapy
Hyperbaric oxygen therapy (HBOT) utilizes 100% oxygen delivery at a pressure greater than 1 atm for the treatment of various emergent medical conditions including carbon monoxide poisoning. The most commonly associated complication of HBOT is middle ear barotrauma (MEB) which occurs when the eustachian tube does not allow air to enter the middle ear space to equalize the pressure between the ambient environment and the inner ear. Patients experiencing MEB usually feel pressure or pain in their ear(s). The spectrum of symptoms ranges from sensation of ear fullness and muffled hearing to severe pain, vertigo and tympanic membrane rupture. HBOT has not been studied. The investigators plan to perform a randomized double blind placebo control trial to determine if pseudoephedrine is effective in decreasing the rate of MEB during HBOT.
COVID-19 may cause severe pneumonitis that require ventilatory support in some patients, the ICU mortality is as high as 62%. Hospitals do not have enough ICU beds to handle the demand and to date there is no effective cure. We explore a treatment administered in a randomized clinical trial that could prevent ICU admission and reduce mortality. The overall hypothesis to be evaluated is that HBO reduce mortality, increase hypoxia tolerance and prevent organ failure in patients with COVID19 pneumonitis by attenuating the inflammatory response.
Clinical Trial – Effect of Self-acupressure on Middle Ear Barotrauma Associated With Hyperbaric Oxygen Therapy
Middle ear barotrauma (MEB) is the most common complication during hyperbaric oxygen therapy
(HBOT). Though Valsalva and Toynbee maneuvers have been proposed to prevent MEB, still some
patients discontinue HBOT due to severe otalgia, hemorrhage or perforation of tympanic
membrane associated with HBOT. Currently, there is no optimal prophylactic management for MEB
associated with HBOT. The aim of this protocol is to investigate the efficacy of
self-acupressure therapy on MEB associated with HBOT.
Hyperbaric oxygen therapy for mild traumatic brain injury persistent postconcussion syndrome: a randomized controlled trial
Abstract: Persistent postconcussion syndrome (PPCS) after mild traumatic brain injury (mTBI) is a significant public health and military problem for which there is limited treatment evidence. The aim of this study was to determine whether forty 150...
Currently, Hyperbaric Oxigen (HBO) is a widely used treatment for several conditions. There
are 14 indications for HBO, officially recognized by the Undersea and Hyperbaric Medical
Society (UHMS), but research is discovering other interesting applications.
HBO plays an important role in enhancing antioxidant defense mechanisms by increasing radical
oxygen species (ROS) and nitric oxide species (NOS). This controlled oxidative stress has
been shown to stop the vicious circle of inflammation – damage – hypoxia already seen in
several diseases. Increased neoangiogenesis has been demonstrated at pressures of 2
atmospheres absolute (ATA), while effects helping ischemic tissues need pressures between 2.5
and 2.8 ATA to develop.
During sports activities, metabolism generates waste products – mostly CO2, lactic acid, but
also ROS. HBO could be useful in modulating antioxidant mechanisms and helping cells in the
recovery after training and sportive competitions.
The authors hypothesize that:
1. HBO can reduce oxidative stress in healthy professional athletes
2. HBO can ameliorate the lactic acid clearance after a maximal exercise
3. HBO at low pressures (L-HBO at 1.45 ATA) is at least comparable to conventional HBO (at
2.5 ATA) in reducing oxidative stress and ameliorating lactic acid clearance after a
The Authors will include healthy athletes. These will be randomly assigned to a control
group, a L-HBO group, or a HBO group. The Authors will assess oxidative stress changes and
lactic acid clearance (testing it after a maximal exercise) before and after 20 L-HBO/HBO
treatments, and after 2 months after the end of treatments.
Clinical Trial – Hyperbaric Oxygen Therapy Compared to Pharmaceutical in Fibromyalgia With Emotional Trauma
The investigators have previously studied the efficacy of hyperbaric oxygen therapy (HBOT) as
a treatment for Fibromyalgia syndrome (FMS) in a prospective, active control, crossover
clinical trial. The results demonstrated significant amelioration of all FMS symptoms, with
significant improvement in life quality; furthermore, the investigators were able to
demonstrate significant neuroplasticity on SPECT imaging, with a decrease of the
hyperactivity in posterior regions and elevation of the reduced activity in frontal areas.
In this study, the investigators intend to both repeat and expand the investigator’s previous
findings, treating FMS patients with history of emotional trauma with HBOT, while performing
an extensive of evaluation both before and after treatment.
In the current study, the investigators plan to compare HBOT to current standard of care of
FMS (pharmacological and non – pharmacological).
Clinical Trial – The Effects of Ilioinguinal Nerve Block on Chronic Pain in Patients in Inguinal Hernia With Spinal Anesthesia
Regional anesthesia is a popular anesthetic method in patients who will undergo an inguinal
hernia operation. Researchers known that pain in the operating area is a complaint that
impairs the quality of life for patients in the long term after the operation. In addition to
regional anesthesia, has planned to investigate the effects of applying another drug near the
surgery area on pain that may develop in the long term.